Altre lingue HLB Life Science Co., Ltd.

Azioni

A067630

KR7067630004

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 18/04/2024			Variaz. 5gg	Var. 1 gen.
16.680 ^KRW	+2,52%		+3,60%	+45,68%

21/03	HLB Life Science Co. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	HLB Life Science Co. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8%	22/03
HLB Life Science Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
HLB Life Science Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
HLB Life Science Co., Ltd. announced that it has received KRW 28.799996266 billion in funding	07/11
HLB SCIENCE Inc. announced that it has received KRW 6.000000045 billion in funding from HLB Life Science Co., Ltd.	26/09/23
HLB SCIENCE Inc. announced that it expects to receive KRW 6.000000045 billion in funding from HLB Life Science Co., Ltd.	18/09/23
HLB Life Science Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23
HLB Life Science Co., Ltd. announced that it has received KRW 8.3 billion in funding from HLB Therapeutics Co.,Ltd.	07/07/23
HLB Life Science Co., Ltd. announced that it expects to receive KRW 8.3 billion in funding from HLB Therapeutics Co.,Ltd.	29/06/23
HLB Life Science Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
HLB innoVation Co.,Ltd. announced that it has received KRW 55.99999522 billion in funding from a group of investors	13/03/23
HLB innoVation Co.,Ltd. announced that it expects to receive KRW 55.99999522 billion in funding from a group of investors	01/02/23
HLB Life Science Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
HLB Life Science Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22
HLB Life Science Co., Ltd. announced that it has received KRW 45 billion in funding	01/07/22
HLB Life Science Co., Ltd. announced that it expects to receive KRW 45 billion in funding	31/05/22
HLB Life Science Co., Ltd. agreed to acquire AIM Inc from Yong Ho Cho and others for KRW 101,900 million.	31/05/22
HLB Life Science Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
HLB Life Science Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	23/03/22
HLB Life Science Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue HLB Life Science Co., Ltd.

Azioni

A067630

KR7067630004

Altre lingue

Filtri